{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T01:19:38Z","timestamp":1785806378869,"version":"3.56.0"},"reference-count":71,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T00:00:00Z","timestamp":1570492800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Rheumatol"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1038\/s41584-019-0308-5","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T17:06:21Z","timestamp":1570554381000},"page":"687-695","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":63,"title":["Palindromic rheumatism as part of the rheumatoid arthritis continuum"],"prefix":"10.1038","volume":"15","author":[{"given":"Kulveer","family":"Mankia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7429-8482","authenticated-orcid":false,"given":"Paul","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,8]]},"reference":[{"key":"308_CR1","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0002-9343(92)90177-D","volume":"93","author":"PA Guerne","year":"1992","unstructured":"Guerne, P. A. & Weisman, M. H. Palindromic rheumatism: part of or apart from the spectrum of\u00a0rheumatoid arthritis. Am. J. Med. 93, 451\u2013460 (1992).","journal-title":"Am. J. Med."},{"key":"308_CR2","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/archinte.1944.00210160025004","volume":"73","author":"P Hench","year":"1944","unstructured":"Hench, P. & Rosenberg, E. F. Palindromic rheumatism. A \u2018new\u2019 oft recurring disease of joints (arthritis, periarthritis, para-arthritis) apparently producing no articular residues. Report of thirty-four cases; its relation to angio-neural arthrosis\u2019, \u2018allergic rheumatism\u2019 and rheumatoid arthritis. Arch. Int. Med. 73, 293\u2013321 (1944).","journal-title":"Arch. Int. Med."},{"key":"308_CR3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.berh.2017.09.014","volume":"31","author":"K Mankia","year":"2017","unstructured":"Mankia, K. & Emery, P. What can palindromic rheumatism tell us? Best Pract. Res. Clin. Rheumatol. 31, 90\u201398 (2017).","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"308_CR4","first-page":"1240","volume":"33","author":"AS Russell","year":"2006","unstructured":"Russell, A. S., Devani, A. & Maksymowych, W. P. The role of anti-cyclic citrullinated peptide antibodies in predicting progression of palindromic rheumatism to rheumatoid arthritis. J. Rheumatol. 33, 1240\u20131242 (2006).","journal-title":"J. Rheumatol."},{"key":"308_CR5","doi-asserted-by":"publisher","first-page":"287","DOI":"10.3109\/03009741003604534","volume":"39","author":"M Tamai","year":"2010","unstructured":"Tamai, M. et al. Contribution of anti-CCP antibodies, proximal interphalangeal joint involvement, HLA-DRB1 shared epitope, and PADI4 as risk factors for\u00a0the development of rheumatoid arthritis in palindromic rheumatism. Scand J. Rheumatol. 39, 287\u2013291 (2010).","journal-title":"Scand J. Rheumatol."},{"key":"308_CR6","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1136\/ard.18.4.330","volume":"18","author":"BM Ansell","year":"1959","unstructured":"Ansell, B. M. & Bywaters, E. G. Palindromic rheumatism. Ann. Rheum. Dis. 18, 330 (1959).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR7","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.3899\/jrheum.090025","volume":"36","author":"E Koskinen","year":"2009","unstructured":"Koskinen, E., Hannonen, P. & Sokka, T. Palindromic rheumatism: longterm outcomes of 60 patients diagnosed in 1967-84. J. Rheumatol. 36, 1873\u20131875 (2009).","journal-title":"J. Rheumatol."},{"key":"308_CR8","first-page":"540","volume":"26","author":"L Gonzalez-Lopez","year":"1999","unstructured":"Gonzalez-Lopez, L. et al. Prognostic factors for the development of rheumatoid arthritis and other connective tissue diseases in patients with palindromic\u00a0rheumatism. J. Rheumatol. 26, 540\u2013545 (1999).","journal-title":"J. Rheumatol."},{"key":"308_CR9","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1136\/ard.25.4.307","volume":"25","author":"S Mattingly","year":"1966","unstructured":"Mattingly, S. Palindromic rheumatism. Ann. Rheum. Dis. 25, 307\u2013317 (1966).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1136\/ard.36.1.56","volume":"36","author":"MA Wajed","year":"1977","unstructured":"Wajed, M. A., Brown, D. L. & Currey, H. L. Palindromic rheumatism. Clinical and serum complement study. Ann. Rheum. Dis. 36, 56\u201361 (1977).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR11","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3109\/03009748709165412","volume":"16","author":"P Hannonen","year":"1987","unstructured":"Hannonen, P., Mottonen, T. & Oka, M. Palindromic\u00a0rheumatism. A clinical survey of sixty\u00a0patients. Scand.\u00a0J. Rheumatol. 16, 413\u2013420 (1987).","journal-title":"Scand J. Rheumatol."},{"key":"308_CR12","first-page":"972","volume":"42","author":"G Salvador","year":"2003","unstructured":"Salvador, G. et al. Prevalence and clinical significance of anti-cyclic citrullinated peptide and antikeratin antibodies in palindromic rheumatism. An abortive form of rheumatoid arthritis? Rheumatology 42, 972\u2013975 (2003).","journal-title":"An abortive form of rheumatoid arthritis? Rheumatology"},{"key":"308_CR13","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s10067-014-2569-3","volume":"33","author":"Y Emad","year":"2014","unstructured":"Emad, Y. et al. In palindromic rheumatism, hand joint involvement and positive anti-CCP antibodies predict RA development after 1 year of follow-up. Clin. Rheumatol. 33, 791\u2013797 (2014).","journal-title":"Clin. Rheumatol."},{"key":"308_CR14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/j.1756-185X.2012.01739.x","volume":"15","author":"A Khabbazi","year":"2012","unstructured":"Khabbazi, A. et al. A multicenter study of clinical and laboratory findings of palindromic rheumatism in Iran. Int. J. Rheum. Dis. 15, 427\u2013430 (2012).","journal-title":"Int. J. Rheum. Dis."},{"key":"308_CR15","doi-asserted-by":"crossref","unstructured":"Mankia K., et al. Identification of a distinct imaging phenotype may improve the management of palindromic rheumatism. Ann. Rheum. Dis. 2018.","DOI":"10.1136\/annrheumdis-2018-214175"},{"key":"308_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.7863\/jum.2009.28.9.1193","volume":"28","author":"HH Chen","year":"2009","unstructured":"Chen, H. H. et al. Association of ultrasonographic findings of synovitis with anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with palindromic rheumatism during active episodes. J. Ultrasound Med. 28, 1193\u20131199 (2009).","journal-title":"J. Ultrasound Med."},{"key":"308_CR17","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1093\/rheumatology\/25.4.345","volume":"25","author":"LR Fisher","year":"1986","unstructured":"Fisher, L. R. et al. HLA antigens in palindromic rheumatism and palindromic onset rheumatoid arthritis. Br. J. Rheumatol. 25, 345\u2013348 (1986).","journal-title":"Br. J. Rheumatol."},{"key":"308_CR18","first-page":"136","volume":"11","author":"JT Gran","year":"1984","unstructured":"Gran, J. T., Husby, G. & Thorsby, E. HLA antigens in\u00a0palindromic rheumatism, nonerosive rheumatoid arthritis and classical rheumatoid arthritis. J.\u00a0Rheumatol. 11, 136\u2013140 (1984).","journal-title":"J. Rheumatol."},{"key":"308_CR19","first-page":"470","volume":"7","author":"P Barbieri","year":"1988","unstructured":"Barbieri, P., Ciompi, M. L., Menicucci, A. & Pasero, G. HLA antigens in palindromic rheumatism. An Italian study. Clin. Rheumatol. 7, 470\u2013473 (1988).","journal-title":"Clin. Rheumatol."},{"key":"308_CR20","first-page":"441","volume":"53","author":"C Bregeon","year":"1986","unstructured":"Bregeon, C. et al. [Palindromic rheumatism. Immunological survey and study of development in 43\u00a0cases]. Rev. Rhum. Mal. Osteoartic. 53, 441\u2013449 (1986).","journal-title":"Rev. Rhum. Mal. Osteoartic"},{"key":"308_CR21","first-page":"2319","volume":"29","author":"WP Maksymowych","year":"2002","unstructured":"Maksymowych, W. P. et al. HLA and cytokine gene polymorphisms in relation to occurrence of palindromic rheumatism and its progression to rheumatoid arthritis. J. Rheumatol. 29, 2319\u20132326 (2002).","journal-title":"J. Rheumatol."},{"key":"308_CR22","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1002\/art.1780301102","volume":"30","author":"PK Gregersen","year":"1987","unstructured":"Gregersen, P. K., Silver, J. & Winchester, R. J. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30, 1205\u20131213 (1987).","journal-title":"Arthritis Rheum."},{"key":"308_CR23","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.3899\/jrheum.120713","volume":"40","author":"M Navalho","year":"2013","unstructured":"Navalho, M. et al. Bilateral evaluation of the hand and\u00a0wrist in untreated early inflammatory arthritis: a\u00a0comparative study of ultrasonography and magnetic resonance imaging. J. Rheumatol. 40, 1282\u20131292 (2013).","journal-title":"J. Rheumatol."},{"key":"308_CR24","doi-asserted-by":"publisher","first-page":"2784","DOI":"10.1002\/art.22755","volume":"56","author":"JD Canete","year":"2007","unstructured":"Ca\u00f1ete, J. D. et al. An unexpectedly high frequency of\u00a0MEFV mutations in patients with anti-citrullinated protein antibody-negative palindromic rheumatism. Arthritis Rheum. 56, 2784\u20132788 (2007).","journal-title":"Arthritis Rheum."},{"key":"308_CR25","doi-asserted-by":"publisher","first-page":"2334","DOI":"10.1002\/art.21923","volume":"54","author":"JD Canete","year":"2006","unstructured":"Ca\u00f1ete, J. D. et al. Association of intermittent hydrarthrosis with MEFV gene mutations. Arthritis Rheum. 54, 2334\u20132335 (2006).","journal-title":"Arthritis Rheum."},{"key":"308_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1136\/bmj.1.5011.139","volume":"1","author":"S Mattingly","year":"1957","unstructured":"Mattingly, S. Intermittent hydrarthrosis. Br. Med. J. 1, 139\u2013143 (1957).","journal-title":"Br. Med. J."},{"key":"308_CR27","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1136\/ard.2006.052928","volume":"65","author":"SK Kim","year":"2006","unstructured":"Kim, S. K., Lee, H. S., Lee, K. W., Bae, S. C. & Jun, J. B. Palindromic rheumatism: different genetic background implies a distinct disease entity. Ann. Rheum. Dis. 65, 1539\u20131540 (2006).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0929-6441(10)60003-3","volume":"18","author":"HCD Chen","year":"2010","unstructured":"Chen, H. C. D. et al. Predicting the progression of palindromic rheumatism to rheumatoid arthritis: the\u00a0role of ultrasonography and anti-cyclic citrullinated peptide antibodies. J. Med. Ultrasound 18 17\u201326 (2010).","journal-title":"J. Med. Ultrasound"},{"key":"308_CR29","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1136\/annrheumdis-2011-200077","volume":"71","author":"S Bugatti","year":"2012","unstructured":"Bugatti, S. et al. Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis. Ann. Rheum. Dis. 71, 625\u2013626 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR30","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3899\/jrheum.131545","volume":"41","author":"S Cabrera-Villalba","year":"2014","unstructured":"Cabrera-Villalba, S. et al. Is there subclinical synovitis in patients with palindromic rheumatism in the intercritical period? A clinical and ultrasonographic study according to anticitrullinated protein antibody status. J. Rheumatol. 41, 1650\u20131655 (2014).","journal-title":"J. Rheumatol."},{"key":"308_CR31","doi-asserted-by":"publisher","unstructured":"Mankia K., D\u2019Agostino M. A., Emery P. Response to: \u2018Ultrasound findings in palindromic rheumatism\u2019 by Sanmarti et al. Ann. Rheum. Dis. https:\/\/doi.org\/10.1136\/annrheumdis-2018-214867 (2018).","DOI":"10.1136\/annrheumdis-2018-214867"},{"key":"308_CR32","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1093\/rheumatology\/27.1.79","volume":"27","author":"DN Golding","year":"1988","unstructured":"Golding, D. N. Sulphasalazine for palindromic rheumatism. Br. J. Rheumatol. 27, 79 (1988).","journal-title":"Br. J. Rheumatol."},{"key":"308_CR33","first-page":"35","volume":"18","author":"W Youssef","year":"1991","unstructured":"Youssef, W., Yan, A. & Russell, A. S. Palindromic rheumatism: a response to chloroquine. J. Rheumatol. 18, 35\u201337 (1991).","journal-title":"J. Rheumatol."},{"key":"308_CR34","first-page":"41","volume":"27","author":"L Gonzalez-Lopez","year":"2000","unstructured":"Gonzalez-Lopez, L., Gamez-Nava, J. I., Jhangri, G., Russell, A. S. & Suarez-Almazor, M. E. Decreased progression to rheumatoid arthritis or other connective tissue diseases in patients with palindromic rheumatism treated with antimalarials. J. Rheumatol. 27, 41\u201346 (2000).","journal-title":"J. Rheumatol."},{"key":"308_CR35","doi-asserted-by":"publisher","unstructured":"Rempenault C. et al. Clinical and structural efficacy of\u00a0hydroxychloroquine in rheumatoid arthritis: a\u00a0systematic review. Arthritis Care Res. https:\/\/doi.org\/10.1002\/acr.23826 (2019).","DOI":"10.1002\/acr.23826"},{"key":"308_CR36","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00124743-199606000-00013","volume":"2","author":"B Rothschild","year":"1996","unstructured":"Rothschild, B. & Yakubov, L. E. Evidence for an effect of hydroxychloroquine in chronic pyrophosphate deposition disease. J. Clin. Rheumatol. 2, 170 (1996).","journal-title":"J. Clin. Rheumatol."},{"key":"308_CR37","first-page":"341","volume":"9","author":"M Schwartzberg","year":"1982","unstructured":"Schwartzberg, M. Prophylactic colchicine therapy in palindromic rheumatism. J. Rheumatol. 9, 341\u2013343 (1982).","journal-title":"J. Rheumatol."},{"key":"308_CR38","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1002\/art.1780340806","volume":"34","author":"D Zemer","year":"1991","unstructured":"Zemer, D., Livneh, A., Danon, Y. L., Pras, M. & Sohar, E. Long-term colchicine treatment in children with familial Mediterranean fever. Arthritis Rheum. 34, 973\u2013977 (1991).","journal-title":"Arthritis Rheum."},{"key":"308_CR39","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","volume":"75","author":"S Ozen","year":"2016","unstructured":"Ozen, S. et al. EULAR recommendations for the management of familial Mediterranean fever. Ann.\u00a0Rheum. Dis. 75, 644\u2013651 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR40","doi-asserted-by":"publisher","DOI":"10.1136\/rmdopen-2017-000550","volume":"3","author":"S Savic","year":"2017","unstructured":"Savic, S. et al. Autoimmune-autoinflammatory rheumatoid arthritis overlaps: a rare but potentially important subgroup of diseases. RMD Open 3, e000550 (2017).","journal-title":"RMD Open."},{"key":"308_CR41","doi-asserted-by":"crossref","unstructured":"van Echteld I., Wechalekar M. D., Schlesinger N., Buchbinder R., Aletaha D. Colchicine for acute gout. Cochrane Database Syst. Rev. 8, CD006190 (2014).","DOI":"10.1002\/14651858.CD006190.pub2"},{"key":"308_CR42","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1136\/annrheumdis-2012-202087","volume":"72","author":"M Andres","year":"2013","unstructured":"Andres, M. & Pascual, E. Anakinra for a refractory case of intermittent hydrarthrosis with a TRAPS-related gene mutation. Ann. Rheum. Dis. 72, 155 (2013).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR43","first-page":"75","volume":"10","author":"J van der Hilst","year":"2016","unstructured":"van der Hilst, J., Moutschen, M., Messiaen, P. E., Lauwerys, B. R. & Vanderschueren, S. Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a\u00a0systematic review of the literature. Biologics 10, 75\u201380 (2016).","journal-title":"Biologics"},{"key":"308_CR44","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/art.39995","volume":"69","author":"I Ben-Zvi","year":"2017","unstructured":"Ben-Zvi, I. et al. Anakinra for colchicine-resistant familial mediterranean fever: a randomized, double-blind, placebo-controlled trial. Arthritis Rheumatol. 69, 854\u2013862 (2017).","journal-title":"Arthritis Rheumatol."},{"key":"308_CR45","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.86336","volume":"1","author":"SR Harrison","year":"2016","unstructured":"Harrison, S. R. et al. Anakinra as a diagnostic challenge and treatment option for systemic autoinflammatory disorders of undefined etiology. JCI Insight 1, e86336 (2016).","journal-title":"JCI Insight"},{"key":"308_CR46","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1136\/ard.2009.108068","volume":"69","author":"L Naumann","year":"2010","unstructured":"Naumann, L. et al. IL1-receptor antagonist anakinra provides long-lasting efficacy in the treatment of refractory adult-onset Still\u2019s disease. Ann. Rheum. Dis. 69, 466\u2013467 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR47","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.1111\/j.1756-185X.2011.01629.x","volume":"14","author":"AP Tran","year":"2011","unstructured":"Tran, A. P. & Edelman, J. Interleukin-1 inhibition by anakinra in refractory chronic tophaceous gout. Int. J. Rheum. Dis. 14, e33\u2013e37 (2011).","journal-title":"Int. J. Rheum. Dis."},{"key":"308_CR48","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1136\/annrheumdis-2011-200990","volume":"71","author":"DM Gerlag","year":"2012","unstructured":"Gerlag, D. M. et al. EULAR recommendations for terminology and research in individuals at risk of rheumatoid arthritis: report from the Study Group for Risk Factors for Rheumatoid Arthritis. Ann. Rheum. Dis. 71, 638\u2013641 (2012).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR49","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1002\/art.39603","volume":"68","author":"K Mankia","year":"2016","unstructured":"Mankia, K. & Emery, P. Preclinical rheumatoid arthritis: progress toward prevention. Arthritis Rheumatol. 68, 779\u2013788 (2016).","journal-title":"Arthritis Rheumatol."},{"key":"308_CR50","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1093\/rheumatology\/keu159","volume":"53","author":"RJ Stack","year":"2014","unstructured":"Stack, R. J. et al. Symptom complexes in patients with seropositive arthralgia and in patients newly diagnosed with rheumatoid arthritis: a qualitative exploration of symptom development. Rheumatology 53, 1646\u20131653 (2014).","journal-title":"Rheumatology"},{"key":"308_CR51","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1136\/annrheumdis-2015-207871","volume":"75","author":"JL Nam","year":"2016","unstructured":"Nam, J. L., Hunt, L., Hensor, E. M. & Emery, P. Enriching case selection for imminent RA: the use of\u00a0anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms \u2014 a cohort study. Ann. Rheu. Dis. 75, 1452\u20131456 (2016).","journal-title":"Ann. Rheu. Dis."},{"key":"308_CR52","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1136\/ard.2008.105759","volume":"69","author":"WH Bos","year":"2010","unstructured":"Bos, W. H. et al. Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study. Ann. Rheum. Dis. 69, 490\u2013494 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR53","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1093\/rheumatology\/kev431","volume":"55","author":"HW van Steenbergen","year":"2016","unstructured":"van Steenbergen, H. W. & van der Helm-van Mil, A. H. Clinical expertise and its accuracy in differentiating arthralgia patients at risk for rheumatoid arthritis from other patients presenting with joint symptoms. Rheumatology 55, 1140\u20131141 (2016).","journal-title":"Rheumatology"},{"key":"308_CR54","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1136\/annrheumdis-2015-208138","volume":"75","author":"HW van Steenbergen","year":"2016","unstructured":"van Steenbergen, H. W., Mangnus, L., Reijnierse, M., Huizinga, T. W. & van der Helm-van Mil, A. H. Clinical factors, anticitrullinated peptide antibodies and MRI-detected subclinical inflammation in relation to progression from clinically suspect arthralgia to arthritis. Ann. Rheum. Dis. 75, 1824\u20131830 (2016).","journal-title":"Ann. Rheum. Dis."},{"issue":"Suppl 2","key":"308_CR55","first-page":"72","volume":"77","author":"L Hunt","year":"2018","unstructured":"Hunt, L. et al. OP0042\u2005In ACPA positive at-risk individuals, which MRI and US findings best predict development of clinical synovitis? Ann. Rheum. Dis. 77 (Suppl 2), 72\u201373 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR56","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.semarthrit.2016.05.002","volume":"46","author":"A Kleyer","year":"2016","unstructured":"Kleyer, A. et al. High prevalence of tenosynovial inflammation before onset of rheumatoid arthritis and its link to progression to RA-A combined MRI\/CT study. Semin. Arthritis Rheum. 46, 143\u2013150 (2016).","journal-title":"Semin. Arthritis Rheum."},{"key":"308_CR57","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1136\/annrheumdis-2018-214331","volume":"78","author":"K Mankia","year":"2019","unstructured":"Mankia, K. et al. MRI inflammation of the hand interosseous tendons occurs in anti-CCP-positive at-risk individuals and may precede the development of clinical synovitis. Ann. Rheum. Dis. 78, 781\u2013786 (2019).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR58","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1136\/ard.2009.121657","volume":"69","author":"G Schett","year":"2010","unstructured":"Schett, G. & Firestein, G. S. Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis. Ann. Rheum. Dis. 69, 787\u2013789 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR59","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1136\/ard.2006.063792","volume":"67","author":"A Duer","year":"2008","unstructured":"Duer, A., Ostergaard, M., Horslev-Petersen, K. & Vallo, J. Magnetic resonance imaging and bone scintigraphy in the differential diagnosis of unclassified arthritis. Ann. Rheum. Dis. 67, 48\u201351 (2008).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR60","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1136\/annrheumdis-2012-202958","volume":"73","author":"A Kleyer","year":"2014","unstructured":"Kleyer, A. et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann. Rheum. Dis. 73, 854\u2013860 (2014).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR61","doi-asserted-by":"publisher","first-page":"2060","DOI":"10.1136\/annrheumdis-2015-208235","volume":"75","author":"JL Nam","year":"2016","unstructured":"Nam, J. L. et al. Ultrasound findings predict progression to inflammatory arthritis in anti-CCP antibody-positive patients without clinical synovitis. Ann. Rheum. Dis. 75, 2060\u20132067 (2016).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR62","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1136\/ard.2008.106658","volume":"69","author":"JE Freeston","year":"2010","unstructured":"Freeston, J. E. et al. A diagnostic algorithm for persistence of very early inflammatory arthritis: the utility of power Doppler ultrasound when added to conventional assessment tools. Ann. Rheum. Dis. 69, 417\u2013419 (2010).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR63","doi-asserted-by":"publisher","unstructured":"Mosor E. et al. I would never take preventive medication! Perspectives and information needs of people who underwent predictive tests for rheumatoid arthritis. Arthritis Care Res. https:\/\/doi.org\/10.1002\/acr.23841 (2019).","DOI":"10.1002\/acr.23841"},{"key":"308_CR64","doi-asserted-by":"publisher","first-page":"R28","DOI":"10.1186\/ar2143","volume":"9","author":"A So","year":"2007","unstructured":"So, A., De Smedt, T., Revaz, S. & Tschopp, J. A pilot study of IL-1 inhibition by anakinra in acute gout. Arthritis Res. Ther. 9, R28 (2007).","journal-title":"Arthritis Res. Ther."},{"key":"308_CR65","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.jbspin.2018.05.008","volume":"86","author":"P Zufferey","year":"2019","unstructured":"Zufferey, P. et al. Efficacy of anakinra in acute hydroxyapatite calcification-induced joint pain: a retrospective study of 23 cases. Joint Bone Spine 86, 83\u201388 (2019).","journal-title":"Joint Bone Spine"},{"key":"308_CR66","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1136\/ard.2010.144063","volume":"70","author":"N Schlesinger","year":"2011","unstructured":"Schlesinger, N. et al. Canakinumab reduces the risk of\u00a0acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study. Ann. Rheum. Dis. 70, 1264\u20131271 (2011).","journal-title":"Ann. Rheum. Dis."},{"key":"308_CR67","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1136\/annrheumdis-2011-200908","volume":"71","author":"N Schlesinger","year":"2012","unstructured":"Schlesinger, N. et al. Canakinumab for acute gouty arthritis in patients with limited treatment options: results from two randomised, multicentre, active-controlled, double-blind trials and their initial extensions. Ann. Rheum Dis. 71, 1839\u20131848 (2012).","journal-title":"Ann. Rheum Dis."},{"key":"308_CR68","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/phr08070","volume":"8","author":"W Clark","year":"2004","unstructured":"Clark, W., Jobanputra, P., Barton, P. & Burls, A. The\u00a0clinical and cost-effectiveness of anakinra for the treatment of rheumatoid arthritis in adults: a\u00a0systematic review and economic analysis. Health Technol. Assess. 8, 1\u2013105, iii-iv, ix-x (2004).","journal-title":"Health Technol. Assess."},{"key":"308_CR69","first-page":"88","volume":"34","author":"IC Scott","year":"2016","unstructured":"Scott, I. C. et al. A randomised trial evaluating anakinra in early active rheumatoid arthritis. Clin. Exp. Rheumatol. 34, 88\u201393 (2016).","journal-title":"Clin. Exp. Rheumatol."},{"key":"308_CR70","first-page":"197","volume":"4","author":"G Pasero","year":"1986","unstructured":"Pasero, G. & Barbieri, P. Palindromic rheumatism: you just have to think about it! Clin. Exp. Rheumatol. 4, 197\u2013199 (1986).","journal-title":"Clin. Exp. Rheumatol."},{"key":"308_CR71","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.3899\/jrheum.120568","volume":"39","author":"R Sanmarti","year":"2012","unstructured":"Sanmarti, R. et al. Palindromic rheumatism with positive anticitrullinated peptide\/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study. J. Rheumatol. 39, 1929\u20131933 (2012).","journal-title":"J. Rheumatol."}],"container-title":["Nature Reviews Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0308-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0308-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0308-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T09:27:32Z","timestamp":1650101252000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41584-019-0308-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,8]]},"references-count":71,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["308"],"URL":"https:\/\/doi.org\/10.1038\/s41584-019-0308-5","relation":{},"ISSN":["1759-4790","1759-4804"],"issn-type":[{"value":"1759-4790","type":"print"},{"value":"1759-4804","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,8]]},"assertion":[{"value":"5 September 2019","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}